AbbVie ABBV
NYSE ABBV
$276.48 +4.06 (+1.49%)
At close: Oct 9, 2026 · 4:00 PM EDT

AbbVie (ABBV) Asset Writedowns and Impairment (2018 - 2024)

Updated

AbbVie's Asset Writedowns and Impairment was $847 million in FY2025, down 81.1% from $4.48 billion in FY2024.

Analysis

AbbVie (ABBV) Asset Writedowns and Impairment (2018 - 2024) Analysis & Trends

From FY2016 onward, AbbVie has reported Asset Writedowns and Impairment for 9 years.

  • Asset Writedowns and Impairment shows a four-year compound annual growth rate of 102.9% (FY2021 to FY2025).
  • The FY2025 figure marks the lowest annual Asset Writedowns and Impairment since FY2022.
  • Per Business Quant data, Asset Writedowns and Impairment in earlier years was $4.48 billion in FY2024 (+5.8%), $4.23 billion in FY2023 (+449.2%), $770 million in FY2022 and $50 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 4.48 Bn
Dec 31, 2023 1.41 Bn
Sep 30, 2023 2.11 Bn
Mar 31, 2023 710.00 Mn
Sep 30, 2022 770.00 Mn
Dec 31, 2018 5.07 Bn
API Access

AbbVie Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ABBV&period=max&api_key=YOUR_API_KEY